Volume 22, Number 6—June 2016
Post-Ebola Measles Outbreak in Lola, Guinea, January–June 20151
In 2014 and 2015, Guinea reported 3,804 confirmed and suspected Ebola cases and 2,536 deaths (1). The consequences of Ebola include social instability, weakened food security, reduced vaccination coverage, and increased public mistrust of healthcare systems (2,3).
Lola, a prefecture in Guinea’s forested area, borders Liberia and Côte d’Ivoire and consists of 9 subprefectures and ≈180,000 inhabitants. During September 2014–February 2015, 159 confirmed and probable Ebola cases in Lola were reported; 137 resulted in death. During this time, the World Health Organization (WHO) Regional Strategic Plan for Immunization 2014–2020 routine measles vaccination plan, which aims for 95% coverage by 2017 (4), was suspended in areas of Guinea where active Ebola virus transmission was reported (5). Furthermore, although supplementary immunization activities are essential to measles vaccination coverage in Guinea, a nationwide catch-up campaign scheduled for the second half of 2014 was interrupted because of the Ebola outbreak and did not reach Lola (6). The previous supplementary immunization activities took place in Guinea in 2012, aiming for 95% coverage among children 9–59 months of age (7). After that campaign, a cross-sectional survey estimated vaccination coverage to be 61% among this age group in the N’Zérékoré region, which includes Lola prefecture (7).
Measles surveillance by the Direction Préfectorale de la Santé (DPS) in Lola is based on standard WHO case definitions (8). In January 2015, a total of 8 suspected measles cases were reported in Lola, with no subprefecture exceeding the WHO Regional Office for Africa definition of a suspected outbreak (5 suspected cases in 1 month) (8). In February 2015, another 20 suspected measles cases were reported in Lola; 12 were in the subprefecture of N’Zoo. A suspected outbreak was declared, and 6 blood specimens from N’Zoo were sent to the national measles reference laboratory in Conakry. Five samples were confirmed positive for measles (1 sample was inadequate for testing), thereby confirming the measles outbreak according to the WHO Regional Office for Africa definition (>3 laboratory-confirmed measles cases in a health district in 1 month) (8). Thereafter, measles transmission intensified, and confirmation of measles cases was symptom-based. In total, DPS reported 702 measles cases in Lola during January 1–June 30, 2015 (Figure). No deaths were reported.
In response to the measles outbreak and in parallel to its Ebola efforts, the WHO Global Outbreak Alert and Response Network (GOARN) field team in Lola worked with DPS to strengthen epidemiologic surveillance, conduct field investigations, assist in social mobilization, and collect case information. Beginning in March 2015, active measles surveillance was reinforced through daily phone calls to regional health centers in each subprefecture of Lola to quickly identify new areas of transmission. In addition, the nongovernmental agency Alima offered free vitamin A supplements to measles patients (9), a valuable strategy for areas with poor nutritional levels and low herd immunity. Meanwhile, Guinea received a large shipment of vaccines by the end of March (6), but these did not arrive in Lola until mid-April. A vaccination campaign was launched on April 18, with a goal of 95% 1-dose coverage for all children in Lola 6 months to 109 years of age (53,720 children).
The measles case database constructed by the WHO GOARN field team covers every subprefecture in Lola and records cases identified during the early phase of the outbreak, during January 23, 2015–April 4, 2015. Although the case data are not exhaustive (n = 284), the database can be used to analyze transmission dynamics. The average and median age of case-patients was 2.8 years and 2.0 years, respectively, substantially lower than the mean age of infection of 5.6 years in Africa (10). Of 284 case-patients, 263 (92.6%) were 0–5 years of age, 17 (6.0%) were 6–15 years of age, and 4 (1.4%) were >15 years of age. This low age distribution is indicative of a disruption in vaccination and also suggests that higher immunity existed among older age groups (11), related to either strong pre-Ebola vaccination coverage or prior exposure to measles. Of 281 cases with reported vaccination status, 267 (95%) were not vaccinated and 14 (5%) were vaccinated; health records did not differentiate between 1- and 2-dose coverage.
Persons in the subprefecture of N’Zoo in Lola benefited from active measles surveillance implemented by a well-organized local health team. N’Zoo was also the first subprefecture population in Lola to receive free vitamin A supplements (beginning March 2015). N’Zoo represents 8.7% of the population of Lola (15,559 inhabitants) but accounted for 30% of reported measles cases in Lola (212/702). Because of its efficiency of surveillance, N’Zoo may offer a better estimate of what occurred throughout the prefecture. Extrapolating the incidence rate from N’Zoo across all of Lola yields 2,450 cases. This figure should be treated with caution, however, because measles transmission dynamics cannot be assumed to have been consistent across Lola. Additionally, over-reporting during measles outbreaks, particularly in areas where active surveillance is implemented, is a possibility when cases are diagnosed principally on the basis of symptoms (12).
Many barriers to an effective response to measles existed in Lola. Healthcare-seeking behaviors declined markedly during the Ebola epidemic (2), which likely contributed to probable underreporting of measles cases, a fact further substantiated by the lack of fatalities reported to DPS. Although there are wide variances in estimates of measles case-fatality rates, a large study has suggested an average case-fatality rate of 3.7% for Africa (13), which would correspond with 26 deaths from the 702 suspected cases reported in Lola during January–June 2015. The lack of reported fatalities may also be related to the effect of the Ebola epidemic on burial practices; any families notifying authorities about deaths would be required to conduct “safe and dignified burials,” a protocol that had been met with resistance by many local groups (2).
Another barrier to response was the late initiation of the vaccination campaign. When the full shipment of vaccines arrived in Lola in mid-April, logistical planning was challenged by shortages of personnel, fuel for automobiles, and appropriate vehicles for traversing difficult terrain during the onset of the rainy season. The campaign is estimated to have reached 92% of the target population, but persons in some urban areas and villages were reluctant to receive vaccinations. The launch of the campaign coincided with reduced measles transmission (Figure), but further modeling research would be required to assess its effect on the course of the outbreak.
In the aftermath of the Ebola epidemic, discussions about strengthening global outbreak response capacities are ongoing (14,15). The front lines of disease surveillance and outbreak detection often occur in rural settings that are understaffed and underresourced. As Guinea transitions to a post-Ebola phase, the field presence of public health doctors may be reduced. This reduction would be unfortunate, because the technical and cultural expertise of the doctors from Guinea in Lola and other similar settings transcends Ebola and could be harnessed to support a wide range of public health activities.
Strengthened investments in local public health systems will be essential to ensure the population of Guinea can recover from the Ebola epidemic and be better protected from future disease outbreaks. Aside from personnel, the public health infrastructure, including surveillance, information and communications technology, and temperature-controlled supply chains, particularly requires attention. Meanwhile, great efforts will also be needed to restore and enhance community trust in medicine and public health (2).
Dr. Suk holds the post of Expert, Emerging Threats and Preparedness, at the European Centre for Disease Prevention and Control. His research interests are focused on public health preparedness and the drivers and determinants of infectious disease.
We thank Patient Kighoma for helpfully comparing notes on measles cases in Lola and for making a strong contribution to measles case management in Lola through coordinating the distribution of Vitamin A supplements. We thank Justin Lessler and Matthew Graham for providing insightful discussion while the outbreak in Lola was underway; and Denis Coulombier, Mike Catchpole, Josep Jansa, Jan Semenza, and 2 anonymous reviewers for providing helpful comments on earlier versions of this manuscript. We also thank Dragos Platon for assisting with the design of the figure.
- World Health Organization. Ebola situation report 30. December 2015 [cited 2016 Apr 4].http://apps.who.int/ebola/sites/default/files/atoms/files//who_ebola_situation_report_30-12-2015.pdf?ua=1&ua=1
- United Nations Development Group. Socio-economic impact of Ebola virus disease in West African countries. New York: United Nations Development Programme; 2015 [cited 2016 Feb 29]. http://reliefweb.int/sites/reliefweb.int/files/resources/ebola-west-africa.pdf
- Takahashi S, Metcalf CJE, Ferrari MJ, Moss WJ, Truelove SA, Tatem AJ, Reduced vaccination and the risk of measles and other childhood infections post-Ebola. Science. 2015;347:1240–2.
- WHO Regional Office for Africa. Regional strategic plan for immunization, 2014–2020. The Organization. 2015:90 [cited 2016 Feb 29].http://www.afro.who.int/index.php?option=com_docman&task=doc_download&gid=9307&Itemid=2593
- Measles and Rubella Initiative. Ebola and measles control activities in Guinea, Liberia and Sierra Leone. 2015 Mar 11 [cited 2015 Dec 10].http://www.measlesrubellainitiative.org/ebola-measles-control-activities-guinea-liberia-sierra-leone/
- UNICEF. Guinea measles situation report, 24 March 2015 [cited 2015 Dec 10].http://www.unicef.org/appeals/files/UNICEF_Guinea_Measles_SitRep_24Mar2015.pdf
- Doumtsop JGD, Malano ER, Diallo IT, Sirimah C. An evaluation of the 2012 measles mass vaccination campaign in Guinea. Pan Afr Med J. 2014;17:4.
- World Health Organization, Regional Office for Africa. Guidance for measles surveillance, December 2004 [cited 2015 Dec 10].http://www.afro.who.int/index.php?option=com_docman&task=doc_download&gid=3675
- ALIMA supports the case management of nearly 800 measles cases in Guinea [in French] [cited 2016 Feb 29]. http://www.alimaong.org/ALIMA-appuie-la-prise-en-charge-de-pres-de-800-cas-de-rougeole-en-Guinee.html
- Ferrari MJ, Grenfell BT, Strebel PM. Think globally, act locally: the role of local demographics and vaccination coverage in the dynamic response of measles infection to control. Philos Trans R Soc Lond B Biol Sci. 2013;368:•••.
- Simons E, Ferrari M, Fricks J, Wannemuehler K, Anand A, Burton A, Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data. Lancet. 2012;379:2173–8.
- Ferrari MJ, Grais RF, Bharti N, Conlan AJK, Bjornstad ON, Wolfson LJ, The dynamics of measles in sub-Saharan Africa. Nature. 2008;451:679–84.
- Wolfson LJ, Strebel PM, Gacic-Dobo M, Hoekstra EJ, McFarland JW, Hersh BS. Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study. Lancet. 2007;369:191–200.
- Moon S, Sridhar D, Pate MA, Jha AK, Clinton C, Delaunay S, Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola. Lancet. 2015;386:2204–21.
- World Health Organization. Advisory Group on Reform of WHO’s Work in Outbreaks and Emergencies. First report. 2015 November 15 [cited 2015 Dec 10]. http://www.who.int/about/who_reform/emergency-capacities/advisory-group/first-report.pdf?ua=1
Suggested citation for this article: Suk JE, Jimenez AP, Kourouma M, Derrough T, Balde M, Honomou P, et al. Post-Ebola measles outbreak in Lola, Guinea, January–June 2015. Emerg Infect Dis. 2016 Jun [date cited]. http://dx.doi.org/10.3201/eid2206.151652
1Preliminary results from this study were presented at the European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE); November 11–13, 2015; Stockholm, Sweden.